Antibody Market, Global Outlook and Forecast 2023-2029

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called �antigens�). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C�sar Milstein and Georges K�hler � scientists at the Roche-funded Basel Institute for Immunology � who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody. This report contains market size and forecasts of Antibody in global, including the following market information:
Global Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antibody Market Sales, 2018-2023, 2024-2029, (KG)
Global top five Antibody companies in 2022 (%)
The global Antibody market was valued at US$ 9354.2 million in 2022 and is projected to reach US$ 13230 million by 2029, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent. 
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Antibody Market Segment Percentages, by Type, 2022 (%)
    IgM
    IgG
    IgA
    Other
Global Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Antibody Market Segment Percentages, by Application, 2022 (%)
    Therapeutic
    Research
    Diagnostic
Global Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Antibody Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antibody revenues share in global market, 2022 (%)
Key companies Antibody sales in global market, 2018-2023 (Estimated), (KG)
Key companies Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche
    Johnson and Johnson
    Merck
    Novartis
    AbbVie
    Amgen
    Pfizer
    Bayer
    Lilly
    Bristol-Myers Squibb
    GlaxoSmithKline
    Biogen
    AstraZeneca
    Sanofi
    Alexion Pharmaceuticals
    Seattle Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antibody, market overview.
Chapter 2: Global Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.